Bevacizumab in macular edema: Functional and anatomic changes in a prospective case series

Retina

Volumn 29, Issue 7, 2009, Pages 941-948

  Forte, Raimondo ^a   Cennamo, Gilda ^a   Vecchio, Elisabetta Chiariello ^a   Tenore, Raffaele ^a   Aufiero, Bernardino ^a   De Crecchio, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Choroidal thickness; Macular thickness; Microperimetry; Optical coherence tomography; Spectral domain optical coherence tomography

Indexed keywords

BEVACIZUMAB;

A SCAN; ADULT; AGED; ARTICLE; CHOROID THICKNESS; CLINICAL ARTICLE; CLINICAL TRIAL; EYE FIXATION; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA EDEMA; RETINA THICKNESS; SCANNING LASER OPHTHALMOSCOPE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CHOROID; FEMALE; HUMANS; MACULAR EDEMA; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; OPHTHALMOSCOPY; PERIMETRY; PROSPECTIVE STUDIES; RETINA; RETINAL DISEASES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY; VISUAL ACUITY;

EID: 68249107078     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181a3b8e7     Document Type: Article

References (36)

1. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999;77:527-543. (Pubitemid 29426311)
2. Kaiser PK. Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases. Am J Ophthalmol 2006;142:660-668.
3. Ng EW, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 2005;40:352-368. (Pubitemid 40942262)
4. Boyd SR, Zachary I, Chakravarthy U, et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol 2002;120:1644-1650. (Pubitemid 36401798)
5. Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin- 6. Am J Ophthalmol 2005;140:256-261. (Pubitemid 41125805)
6. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-335. (Pubitemid 41073112)
7. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005;36:336-339. (Pubitemid 41073113)
8. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006;26:279-284. (Pubitemid 44318180)
9. Avery RL, Pieramici DJ, Rabena MD, Castellarin AD, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-372.e5.
10. Spaide RF, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006;26:383-390. (Pubitemid 44197628)
11. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004;24(Suppl 5):S3-S19.
12. Wojtkowski M, Srinivasan V, Fujimoto JG, et al. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2005; 112:1734-1746. (Pubitemid 41400010)
13. Srinivasan VJ, Wojtkowski M, Witkin AJ, et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2006;113:2054.e1-e14. (Pubitemid 44635713)
14. Fujii GY, De Juan E Jr, Humayun MS, Sunness JS, Chang TS, Rossi JV. Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 2003;136:1067-1078.
15. Cennamo G, Rosa N, Iaccarino G, La Rana A, Pasquariello A. Macula study with standardized echography. Acta Ophthalmol Scand 1996;74:178-181.
16. Atta HR, Byrne SF. The findings of standardized echography for choroidal folds. Arch Ophthalmol 1988;106:1234-1241.
17. Bashshur ZF, Haddad ZA, Schakal A, Jaafar RF, Saab M, Noureddin BN. Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study. Am J Ophthalmol 2008;145:249-256.
18. Kriechbaum K, Michels S, Prager F, et al. Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol 2008;92:518-522.
19. Ferrara DC, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol 2007;144:864-871. (Pubitemid 350122344)
20. Mori F, Ishiko S, Kitaya N, et al. Scotoma and fixation patterns using scanning laser ophthalmoscope microperimetry in patients with macular dystrophy. Am J Ophthalmol 2001;132:897-902. (Pubitemid 33122170)
21. Rohrschneider K, Bültmann S, Glück R, Kruse FE, Fendrich T, Volcker HE. Scanning laser ophthalmoscope fundus perimetry before and after laser photocoagulation for clinically significant diabetic macular edema. Am J Ophthalmol 2000;129:27-32. (Pubitemid 30026165)
22. Sunness JS, Applegate CA, Haselwood D, Rubin GS. Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease. Ophthalmology 1996;103:1458-1466. (Pubitemid 26353053)
23. Mori F, Ishiko S, Kitaya N, et al. Use of scanning laser ophthalmoscope microperimetry in clinically significant macular edema in type 2 diabetes mellitus. Jpn J Ophthalmol 2002;46:650-655. (Pubitemid 36132321)
24. Ishiko S, Ogasawara H, Yoshida A, Hanada K. The use of scanning laser ophthalmoscope microperimetry to detect visual impairment caused by macular photocoagulation. Ophthalmic Surg Lasers 1998;29:95-98. (Pubitemid 28090982)
25. Rohrschneider K, Blankenagel A, Kruse FE, Fendrich T, Volcker HE. Macular function testing in a German pedigree with North Carolina macular dystrophy. Retina 1998;18:453-459. (Pubitemid 30387583)
26. Varano M, Scassa C, Capaldo N, Sciamanna M, Parisi V. Development of macular pseudoholes: a 36-month period of follow-up. Retina 2002;22:435-442. (Pubitemid 35025519)
27. Acosta F, Lashikari K, Reynaud X, Jalkh AE, Van de Velde F, Chedid N. Characterization of functional changes in macular holes and cysts. Ophthalmology 1991;98:1820-1823.
28. Ergun E, Maar N, Radner W, Barbazetto I, Schmidt-Erfurth U, Stur M. Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 2003;110:65-69. (Pubitemid 36068728)
29. Midena E, Radin PP, Pilotto E, Ghirlando A, Convento E, Varano M. Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study. Semin Ophthalmol 2004;19:55-61. (Pubitemid 39658410)
30. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-583.
31. Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol 2003;121:695-706. (Pubitemid 36554473)
32. Wojtkowski M, Srinivasan VJ, Ko TH, Fujimoto JG, Kowalczyk A, Duker JS. Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. Opt Express 2004;12:2404-2422.
33. Ko TH, Fujimoto JG, Duker JS, et al. Comparison of ultra-high- and standard-resolution optical coherence tomography for imaging macular hole pathology and repair. Ophthalmology 2004;111:2033-2043.
34. Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik JM, Jr., Yannuzzi LA. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol 2008;145:509-517.
35. Kozak I, Morrison VL, Clark TM, et al. Discrepancy between fluorescein angiography and optical coherence tomography in detection of macular disease. Retina 2008; 28:538-544. (Pubitemid 351589561)
36. Ladewig MS, Karl SE, Hamelmann V, et al. Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2008;246:17-25. (Pubitemid 350162680)